Jason Bock

Dr. Bock is the Vice President and Head of Biologics Product Development at MD Anderson Cancer Center. In this role, Dr. Bock works with MD Anderson’s Therapeutics Discovery team, including world-class oncology researchers and clinicians, to create life-saving transformational medicines quickly, safely, and effectively. Before joining MD Anderson, Dr. Bock spent 20 years in small, medium, and large biotech and biopharma companies (including Human Genome Sciences, CoGenesys, and TEVA) developing biologic therapeutics. He has brought 15 novel drugs through preclinical development into clinical studies and has driven three biologics through the clinic to commercialization globally. He received his Ph.D. from Stanford University in Molecular & Cellular Physiology.